Huntington's Disease Research

Huntington's disease is a neurodegenerative disease characterized by cognitive decline and motor dysfunction. It is a genetic disorder which results in the production of mutant huntingtin protein (mHtt). This protein aggregates in the cell cytoplasm and nucleus, affecting cellular function.

Huntington's Disease Research Products Targets

Products for Huntington's Disease Research - Page 34

Cat.No. Product Name Information/Activity
BCC6567 (±)-trans-ACPD trans-ACPD, a metabotropic receptor agonist, produces calcium mobilization and an inward current in cultured cerebellar Purkinje neurons.
BCC6910 CHPG CHPG is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells. CHPG protects against traumatic brain injury (TBI) in vitro and in vivo by activation of the ERK and Akt signaling pathways.
BCC7755 CHPG Sodium salt CHPG sodium salt is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells. CHPG sodium salt protects against traumatic brain injury (TBI) in vitro and in vivo by activation of the ERK and Akt signaling pathways..
BCC6613 (RS)-3,5-DHPG 19641-83-9
BCC6802 (S)-3,5-DHPG 162870-29-3
BCC6604 (RS)-3-Hydroxyphenylglycine 31932-87-3
BCC6605 (S)-3-Hydroxyphenylglycine 71301-82-1
BCC7653 NPEC-caged-(1S,3R)-ACPD 1315379-60-2
BCC6568 L-Quisqualic acid 52809-07-1
BCC6558 S-Sulfo-L-cysteine sodium salt 7381-67-1